반응식
C(N(CC)CC)C.[F:8][C:9]1[C:14]([F:15])=[CH:13][CH:12]=[CH:11][C:10]=1[C@H:16]1[CH2:22][N:21]2[CH:23]([CH2:26][CH3:27])[CH2:24][N:25]=[C:20]2[C@H:19]([NH2:28])[CH2:18][CH2:17]1.[O:29]=[C:30]1[NH:38][C:33]2=[N:34][CH:35]=[CH:36][CH:37]=[C:32]2[N:31]1[CH:39]1[CH2:44][CH2:43][N:42]([C:45](Cl)=[O:46])[CH2:41][CH2:40]1.C(=O)(O)[O-].[Na+]>ClCCl>[F:8][C:9]1[C:14]([F:15])=[CH:13][CH:12]=[CH:11][C:10]=1[C@H:16]1[CH2:22][N:21]2[CH:23]([CH2:26][CH3:27])[CH2:24][N:25]=[C:20]2[C@H:19]([NH:28][C:45]([N:42]2[CH2:41][CH2:40][CH:39]([N:31]3[C:32]4[C:33](=[N:34][CH:35]=[CH:36][CH:37]=4)[NH:38][C:30]3=[O:29])[CH2:44][CH2:43]2)=[O:46])[CH2:18][CH2:17]1참가 물질
6
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
Triethylamine (17 μL, 0.124 mmol) was added to a solution of the (6S,9R)-6-(2,3-difluorophenyl)-3-ethyl-2,5,6,7,8,9-hexahydro-3H-imidazo[1,2-a]azepin-9-amine (13 mg, 0.035 mmol) and 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carbonyl chloride (15 mg, 0.053 mmol) in dichloromethane (1 mL). After 18 h, saturated aqueous sodium bicarbonate was added and the mixture was extracted with dichloromethane (3×). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated. Purification by reverse phase HPLC(C-18, 95% water/acetonitrile 30% water/acetonitrile with 0.1% trifluoroacetic acid) gave the title compound (8 mg). MS 538.2710 (M+1).
후처리
- extractionthe mixture was extracted with dichloromethane (3×)
- dry with materialThe combined organic extracts were dried over sodium sulfate
- filtrationfiltered
- concentrationconcentrated
- customPurification by reverse phase HPLC(C-18, 95% water/acetonitrile 30% water/acetonitrile with 0.1% trifluoroacetic acid)
출처 및 근거
- ORD 기록
- ord-3f272dfef6e9454b9e4770df6c802e7a
- 출처 데이터셋
- uspto-grants-2010_06
- 특허 번호
- US07732438B2
연결된 노트
불러오는 중…